Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma

Clinical Endocrinology

Volumn 69, Issue 6, 2008, Pages 957-962

  Cherk, Martin H ^a,b   Kalff, Victor ^b   Yap, Kenneth S K ^b   Bailey, Michael ^b   Topliss, Duncan ^a   Kelly, Michael J ^b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; STEROID;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG UPTAKE; FEMALE; FOLLOW UP; HUMAN; IODINE 131 UPTAKE TEST; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; THYROID CARCINOMA; THYROID SURGERY; THYROIDECTOMY; THYROIDITIS; TREATMENT OUTCOME;

DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IODINE RADIOISOTOPES; NEOPLASM, RESIDUAL; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY; THYROIDITIS;

EID: 55949098680     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03276.x     Document Type: Article

References (25)

1. Mazzaferri, E.L. Kloos, R.T. (2001) Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 86, 1447 1463.
2. Pacini, F., Schlumberger, M., Harmer, C., Berg, G.G., Cohen, O., Duntas, L., Jamar, F., Jarzab, B., Limbert, E., Lind, P., Reiners, C., Sanchez Franco, F., Smit, J. Wiersinga, W. (2005) Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report. European Journal of Endocrinology, 153, 651 659.
3. Pacini, F., Schlumberger, M., Dralle, H., Elisei, R., Smit, J.W. Wiersinga, W. (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. European Journal of Endocrinology, 154, 787 803.
4. Wartofsky, L., Sherman, S.I., Gopal, J., Schlumberger, M. Hay, I.D. (1998) The use of radioactive iodine in patients with papillary and follicular thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 83, 4195 4203.
5. DeGroot, L.J., Kaplan, E.L., McCormick, M. Straus, F.H. (1990) Natural history, treatment, and course of papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 71, 414 424.
6. Zidan, J., Hefer, E., Iosilevski, G., Drumea, K., Stein, M.E., Kuten, A. Israel, O. (2004) Efficacy of I131 ablation therapy using different doses as determined by postoperative thyroid scan uptake in patients with differentiated thyroid cancer. International Journal of Radiation Oncology Biology Physics, 59, 1330 1336.
7. Bal, C.S., Kumar, A. Pant, G.S. (2004) Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients. Journal of Clinical Endocrinology and Metabolism, 89, 1666 1673.
8. Samaan, N.A., Maheshwari, Y.K., Nader, S., Hill, C.S. Jr., Schultz, P.N., Haynie, T.P., Hickey, R.C., Clark, R.L., Goepfert, H., Ibanez, M.L. Litton, C.E. (1983) Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. Journal of Clinical Endocrinology and Metabolism, 56, 1131 1138.
9. Massin, J.P., Savoie, J.C., Garnier, H., Guiraudon, G., Leger, F.A. Bacourt, F. (1984) Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment. Cancer, 53, 982 992.
10. Coover, L.R., Silberstein, E.B., Kuhn, P.J. Graves, M.W. (2000) Therapeutic 131I in outpatients: a simplified method conforming to the Code of Federal Regulations, title 10, part 35.75. Journal of Nuclear Medicine, 41, 1868 1875.
11. Panzegrau, B., Gordon, L. Goudy, G.H. (2005) Outpatient therapeutic 131I for thyroid cancer. Journal of Nuclear Medicine Technology, 33, 28 30.
12. Caldwell, C.B. Ehrlich, L.E. (1999) Outpatient treatment of thyroid cancer using high doses of iodine 131. Canadian Association Radiological Journal, 50, 331 336.
13. Grigsby, P.W., Siegel, B.A., Baker, S. Eichling, J.O. (2000) Radiation exposure from outpatient radioactive iodine (131I) therapy for thyroid carcinoma. Journal of the American Medical Association, 283, 2272 2274.
14. Burmeister, L.A., du Cret, R.P. Mariash, C.N. (1991) Local reactions to radioiodine in the treatment of thyroid cancer. American Journal of Medicine, 90, 217 222.
15. Greene, F.L. (2002) American Joint Committee on Cancer American Cancer Society. AJCC Cancer Staging Manual, 6th edn. Springer, New York. 2002.
16. McCowen, K.D., Adler, R.A., Ghaed, N., Verdon, T. Hofeldt, F.D. (1976) Low dose radioiodide thyroid ablation in postsurgical patients with thyroid cancer. American Journal of Medicine, 61, 52 58.
17. Ramacciotti, C., Pretorius, H.T., Line, B.R., Goldman, J.M. Robbins, J. (1982) Ablation of nonmalignant thyroid remnants with low doses of radioactive iodine: concise communication. Journal of Nuclear Medicine, 23, 483 489.
18. Johansen, K., Woodhouse, N.J. Odugbesan, O. (1991) Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer. Journal of Nuclear Medicine, 32, 252 254.
19. Mazzaferri, E.L. Jhiang, S.M. (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. American Journal of Medicine, 97, 418 428.
20. 131I for remnant ablation in patients with differentiated thyroid carcinoma. Cancer, 77, 2574 2580.
21. Hodgson, D.C., Brierley, J.D., Tsang, R.W. Panzarella, T. (1998) Prescribing 131Iodine based on neck uptake produces effective thyroid ablation and reduced hospital stay. Radiotherapy and Oncology, 47, 325 330.
22. 131I activity for remnant ablation in patients with differentiated thyroid cancer: a systematic review. Journal of Clinical Endocrinology and Metabolism, 92, 28 38.
23. Degroot, L.J. Reilly, M. (1982) Comparison of 30- and 50-mCi doses of iodine-131 for thyroid ablation. Annals of Internal Medicine, 96, 51 53.
24. 131I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal. Journal of Clinical Endocrinology and Metabolism, 87, 4063 4068.
25. Pilli, T., Brianzoni, E., Capoccetti, F., Castagna, M.G., Fattori, S., Poggiu, A., Rossi, G., Ferretti, F., Guarino, E., Burroni, L., Vattimo, A., Cipri, C. Pacini, F. (2007) A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 92, 3542 3546.